Adverum Biotechnologies, Inc. Contracts & Agreements

Form of Pre-Funded Warrant (Filed With SEC on February 5, 2024)

Form of Securities Purchase Agreement (Filed With SEC on February 5, 2024)

Form of Registration Rights Agreement (Filed With SEC on February 5, 2024)

Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Richard Beckman, M.D., dated as of May 24, 2023 (Filed With SEC on August 10, 2023)

Consulting Agreement between Adverum Biotechnologies, Inc. and Richard Beckman, M.D., dated as of June 1, 2023 (Filed With SEC on August 10, 2023)

Employment Offer Letter between Adverum Biotechnologies, Inc. and Linda Rubinstein, dated as of August 3, 2023 (Filed With SEC on August 10, 2023)

Form of Change in Control and Severance Agreement for executive officers other than the chief executive officer (Filed With SEC on August 10, 2023)

Third Amendment to Lease and First Amendment to Consent to Sublease between Adverum NC, LLC (a wholly owned subsidiary of the Company), ARE-NC REGION NO. 21, LLC and Jaguar Gene... (Filed With SEC on May 11, 2023)

Sales Agreement, dated May 11, 2023 (Filed With SEC on May 11, 2023)

Third Amendment to Lease (Partial Lease Termination) between Adverum Biotechnologies, Inc. and HCP LS Redwood City, LLC, dated as of March 24, 2023 (Filed With SEC on March 30, 2023)

Fourth Amendment to Lease between Adverum Biotechnologies, Inc. and HCP LS Redwood City, LLC, dated as of March 24, 2023 (Filed With SEC on March 30, 2023)

Confidential Consulting Agreement between Adverum Biotechnologies, Inc. and FLG Partners, LLC, dated as of November 22, 2022 (Filed With SEC on March 30, 2023)

Employment Agreement between Adverum Biotechnologies, Inc. and John Rakow, dated as of January 2 (Filed With SEC on August 11, 2022)

Promotion Letter between Adverum Biotechnologies, Inc. and John Rakow, dated as of July 1 (Filed With SEC on August 11, 2022)

Promotion Letter between Adverum Biotechnologies, Inc. and John Rakow, dated as of June 4, 2022 (Filed With SEC on August 11, 2022)

Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Rupert D'Souza, dated as of June 7, 2022 (Filed With SEC on August 11, 2022)

Consulting Agreement between Adverum Biotechnologies, Inc. and Nancy E. Pecota, dated as of June 29, 2022 (Filed With SEC on August 11, 2022)

Amended and Restated (Filed With SEC on August 11, 2022)

Second Amendment to Lease (Partial Lease Termination) between Adverum Biotechnologies, Inc. and HCP LS Redwood City, LLC, dated as of November 1, 2021 (Filed With SEC on March 29, 2022)

Sublease Agreement between Adverum Biotechnologies, Inc. and Revolution Medicines, Inc., dated as of November 1, 2021 (Filed With SEC on March 29, 2022)

Sublease Agreement between Adverum NC, LLC and Jaguar Gene Therapy, LLC, dated as of October 26, 2021 (Filed With SEC on March 29, 2022)

Form of Performance Stock Unit Award Grant Notice and Performance Stock Unit Award Agreement under the 2014 Equity Incentive Award Plan (Filed With SEC on March 29, 2022)

Form of Change in Control (Filed With SEC on March 29, 2022)

Employment Agreement between Adverum Biotechnologies, Inc. and Brigit Riley, dated as of May 21, 2021 (Filed With SEC on March 29, 2022)

Employment Agreement between Adverum Biotechnologies, Inc. and Rupert D'Souza, dated as of November 12, 2021 (Filed With SEC on March 29, 2022)

Employment Agreement (Filed With SEC on March 29, 2022)

Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Angela Thedinga, dated October 1, 2021 (Filed With SEC on November 4, 2021)

Consulting Agreement between Adverum Biotechnologies, Inc. and Angela Thedinga, dated October 1, 2021 (Filed With SEC on November 4, 2021)

First Lease Amendment by and between HCP LS Redwood City, LLC and Adverum Biotechnologies, Inc., dated (Filed With SEC on August 5, 2021)

Consulting Agreement between Adverum Biotechnologies, Inc. and Leone Patterson, dated June 24, 2021 (Filed With SEC on August 5, 2021)

Employment Offer Letter with Julie Clark, dated April 2, 2020 (Filed With SEC on August 5, 2021)

Promotion Letter with Julie Clark, dated May 22, 2021 (Filed With SEC on August 5, 2021)

Change in Control and Severance Agreement with Julie Clark, dated May 25, 2021 (Filed With SEC on August 5, 2021)

Employment Offer Letter with Chris DeRespino, dated February 1, 2021 (Filed With SEC on August 5, 2021)

Change in Control and Severance Agreement with Chris DeRespino, dated February 1, 2021 (Filed With SEC on August 5, 2021)

Separation Agreement between Adverum Biotechnologies, Inc. and Aaron Osborne, dated April 7, 2021 (Filed With SEC on May 6, 2021)

Consulting Agreement between Adverum Biotechnologies, Inc. and Aaron Osborne, dated March 18, 2021 (Filed With SEC on May 6, 2021)

Separation Agreement between Adverum Biotechnologies, Inc. and Thomas Leung, dated February 2, 2021 (Filed With SEC on May 6, 2021)

Consulting Agreement between Adverum Biotechnologies, Inc. and Thomas Leung, dated February 2, 2021 (Filed With SEC on May 6, 2021)

Lease Agreement and Letter Agreement by and between Adverum NC, LLC (a wholly owned subsidiary of Adverum Biotechnologies, Inc.) and ARE-NC REGION NO. 21, LLC, dated January 8,... (Filed With SEC on May 6, 2021)

Non-Employee Director Compensation Policy, effective March 31, 2021 (Filed With SEC on May 6, 2021)

Non-Employee Director Compensation Policy, effective May 5, 2021 (Filed With SEC on May 6, 2021)

Description of Common Stock (Filed With SEC on March 1, 2021)

Common Stock Sales Agreement, dated December 17, 2020 (Filed With SEC on December 17, 2020)

Underwriting Agreement, dated August 12, 2020 (Filed With SEC on August 13, 2020)

Employment Offer Letter with Laurent Fischer, dated (Filed With SEC on August 10, 2020)

Change in Control and Severance Agreement Laurent Fischer, dated (Filed With SEC on August 10, 2020)

Amended and Restated Offer Letter with Leone Patterson, dated (Filed With SEC on August 10, 2020)

Amended and Restated Change in Control and Severance Agreement with Leone Patterson, dated (Filed With SEC on August 10, 2020)

Amended and Restated Non-Employee Director Compensation Policy, effective June 22, 2020 (Filed With SEC on August 10, 2020)

Adverum Biotechnologies, Inc. Amended and Restated 2006 Equity Incentive Plan (Filed With SEC on August 10, 2020)

Adverum Biotechnologies, Inc. Amended and Restated 2014 Equity Incentive Plan (Filed With SEC on August 10, 2020)

Adverum Biotechnologies, Inc. Amended and Restated 2017 Inducement Plan (Filed With SEC on August 10, 2020)

Form of Indemnification Agreement for Directors and Executive Officers (Filed With SEC on May 28, 2020)

Employment Agreement, dated (Filed With SEC on May 28, 2020)

Promotion Letter, dated February 21, 2020, between Adverum Biotechnologies, Inc. and Angela Thedinga (Filed With SEC on May 28, 2020)

Description of Common Stock (Filed With SEC on March 12, 2020)

Non-Employee Director Compensation Policy, effective December 13, 2019 (Filed With SEC on March 12, 2020)

Underwriting Agreement, dated February 11, 2020 (Filed With SEC on February 12, 2020)

Separation Letter and Consulting Agreement, dated September 3, 2019 and September 6, 2019, respectively, between Adverum Biotechnologies, Inc. and Jennifer Cheng (Filed With SEC on November 7, 2019)

Non-Employee Director Compensation Policy, effective August 15, 2019 (Filed With SEC on November 7, 2019)

Employment Agreement, dated February 28, 2019, among Adverum Biotechnologies, Inc. and Aaron Osborne (Filed With SEC on November 7, 2019)

Employment Agreement, dated October 11, 2019, among Adverum Biotechnologies, Inc. and Peter Soparkar (Filed With SEC on November 7, 2019)

Separation and Consulting Agreement, dated July 31, 2019, between Adverum Biotechnologies, Inc. and Mehdi Gasmi (Filed With SEC on November 7, 2019)

Separation Letter, dated May 1, 2019, between Adverum Biotechnologies, Inc. and Paul Cleveland (Filed With SEC on August 8, 2019)

Employment Agreement, dated February 27, 2019, with Thomas Leung (Filed With SEC on May 8, 2019)

Cooperation Agreement, dated as of May 1, 2019, among Adverum Biotechnologies, Inc., The Sonic Fund II, L.P. and Lawrence Kam (Filed With SEC on May 2, 2019)

Adverum Biotechnologies, Inc. 2014 Equity Incentive Award Plan, as amended and restated (Filed With SEC on March 6, 2019)

Adverum Biotechnologies, Inc. 2014 Employee Stock Purchase Plan, as amended and restated (Filed With SEC on March 6, 2019)

Amendment to the Change in Control and Severance Agreement for Mehdi Gasmi (Filed With SEC on March 6, 2019)

2017 Inducement Plan, as amended and restated (Filed With SEC on March 6, 2019)

Exclusive License Agreement, between the Company and the Regents of the University of California (UC), dated June 17, 2013 (the UC License) (Filed With SEC on March 6, 2019)

License Agreement, between the Company and Virovek, Inc. (Virovek), dated October 12, 2011 (the Virovek License) (Filed With SEC on March 6, 2019)

Amended and Restated Offer Letter with Leone Patterson, dated October 24, 2018 (Filed With SEC on March 6, 2019)

Change in Control and Severance Agreement with Leone Patterson, dated October 24, 2018 (Filed With SEC on March 6, 2019)

Amber Salzman Separation Agreement (Filed With SEC on November 8, 2018)

Athena Countouriotis Separation Agreement (Filed With SEC on November 8, 2018)

Lease dated as of June 28, 2018, between Adverum Biotechnologies, Inc. and HCP LS Redwood City, LLC (Filed With SEC on August 8, 2018)

June 5, 2018, amendment to Editas Agreement (Filed With SEC on August 8, 2018)

Non-Employee Director Compensation Arrangements (Filed With SEC on August 8, 2018)

Amendment to Collaboration, Option and License Agreement with Editas Medicine, Inc., dated January 25, 2018 (Filed With SEC on March 6, 2018)

Adverum Biotechnologies, Inc. 2014 Equity Incentive Award Plan (Filed With SEC on March 6, 2018)

Form of Stock Option Grant Notice and Stock Option Agreement under the 2014 Equity Incentive Award Plan (Filed With SEC on March 6, 2018)

Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2014 Equity Incentive Award Plan (Filed With SEC on March 6, 2018)

Adverum Biotechnologies, Inc. 2014 Employee Stock Purchase Plan (Filed With SEC on March 6, 2018)

Offer Letter, dated May 4, 2015, by and between Avalanche Biotechnologies, Inc. and Jennifer Cheng, Ph.D (Filed With SEC on March 6, 2018)

Form of Change in Control Severance Agreement for executive officers other than the chief executive officer (Filed With SEC on March 6, 2018)

Release Agreement, dated as of October 3, 2017, by and between the Company and Steven Schwartz, M.D (Filed With SEC on March 6, 2018)

Underwriting Agreement, dated February 8, 2018 (Filed With SEC on February 9, 2018)

Separation Agreement, entered into September 1, 2017, by and between Adverum Biotechnologies, Inc. and Samuel B. Barone, M.D (Filed With SEC on September 1, 2017)

[ADVERUM BIOTECHNOLOGIES, INC. LETTERHEAD] (Filed With SEC on June 20, 2017)

ADVERUM BIOTECHNOLOGIES, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on June 20, 2017)

Amendment to January 29, 2016 Employment Offer Letter Agreement (Filed With SEC on March 9, 2017)

Addendum to November 19, 2015 Offer Letter- Paul Cleveland (Filed With SEC on March 9, 2017)

COLLABORATION, OPTION AND LICENSE AGREEMENT (Filed With SEC on November 8, 2016)

Amended and Restated Master Services Agreement (Filed With SEC on August 9, 2016)

LICENSE AGREEMENT BETWEEN ANNAPURNA THERAPEUTICS LIMITED AND CORNELL UNIVERSITY FOR [***] CTL CONTRACT NO. C2016-11-10546 (Filed With SEC on August 9, 2016)

LICENSE AGREEMENT BETWEEN ANNAPURNA THERAPEUTICS LIMITED AND CORNELL UNIVERSITY FOR [***] CTL CONTRACT NO. C2016-11-10547 TABLE OF CONTENTS (Filed With SEC on August 9, 2016)

LICENSE AGREEMENT BETWEEN ANNAPURNA THERAPEUTICS LIMITED AND CORNELL UNIVERSITY FOR [***] CTL CONTRACT NO. C2016-11-10548 TABLE OF CONTENTS (Filed With SEC on August 9, 2016)

License Agreement (Filed With SEC on August 9, 2016)

LICENSE AGREEMENT (Filed With SEC on August 9, 2016)

AMENDMENT N1 TO LICENSE AGREEMENT N12364A10 (Filed With SEC on August 9, 2016)

www.adverumbio.com (Filed With SEC on June 13, 2016)

ADVERUM BIOTECHNOLOGIES, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on June 13, 2016)

AVALANCHE BIOTECHNOLOGIES, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on May 12, 2016)

1035 OBrien Drive, Menlo Park, CA 94025 Tel ###-###-#### | Fax ###-###-#### (Filed With SEC on May 12, 2016)

AVALANCHE BIOTECHNOLOGIES, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on May 12, 2016)

AVALANCHE BIOTECHNOLOGIES, INC. INDUCEMENT AWARD STOCKOPTION GRANT NOTICE (Filed With SEC on May 12, 2016)

AMENDMENT NO. 1 TO ACQUISITION AGREEMENT (Filed With SEC on April 7, 2016)

SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on March 4, 2016)

Consulting Agreement (Filed With SEC on March 4, 2016)

ACQUISITION AGREEMENT by and among AVALANCHEBIOTECHNOLOGIES, INC., ANNAPURNA THERAPEUTICS SAS, THE CONTRIBUTORS, and SHAREHOLDER REPRESENTATIVE SERVICES LLC as the CONTRIBUTORS... (Filed With SEC on February 1, 2016)

SUPPORT AND VOTING AGREEMENT (Filed With SEC on February 1, 2016)

[Signature page immediately follows] (Filed With SEC on February 1, 2016)

AVALANCHE BIOTECHNOLOGIES, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on February 1, 2016)

[Signature page immediately follows] (Filed With SEC on November 20, 2015)

AVALANCHE BIOTECHNOLOGIES, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on November 20, 2015)

AVALANCHE BIOTECHNOLOGIES, INC. INDUCEMENT AWARD STOCKOPTION GRANT NOTICE (Filed With SEC on November 20, 2015)

AMENDMENT TO CHANGE INCONTROL AND SEVERANCE AGREEMENT (Filed With SEC on August 13, 2015)

[Avalanche Biotechnologies, Inc. letterhead] (Filed With SEC on August 13, 2015)

SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on July 23, 2015)

[Avalanche Biotechnologies, Inc. letterhead] (Filed With SEC on July 23, 2015)

[] Shares Avalanche Biotechnologies, Inc. UNDERWRITING AGREEMENT (Filed With SEC on January 5, 2015)

EXHIBIT A EMPLOYEE PROPRIETARY INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT Avalanche Biotechnologies, Inc. EMPLOYEE CONFIDENTIALITY AND INVENTIONS ASSIGNMENT AGREEMENT (Filed With SEC on December 18, 2014)

SECOND AMENDMENT TO LEASE 1035 OBrien Drive MenloPark, California 94025 (Filed With SEC on November 4, 2014)

FIRST AMENDMENT TO LEASE 1035 OBrien Drive MenloPark, California 94025 (Filed With SEC on September 12, 2014)

EXCLUSIVE LICENSE BETWEEN AVALANCHEBIOTECHNOLOGIES, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR USE OF RECOMBINANTGENE DELIVERY VECTORS FOR TREATING OR PREVENTING... (Filed With SEC on July 29, 2014)

RESEARCH COLLABORATION AND LICENSE AGREEMENT By and Between AVALANCHEBIOTECHNOLOGIES, INC. and REGENERON PHARMACEUTICALS, INC. Dated as of May 1, 2014 (Filed With SEC on July 29, 2014)

[Number of Shares] Avalanche Biotechnologies, Inc. UNDERWRITING AGREEMENT (Filed With SEC on July 25, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. 2014 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on July 25, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE,SCOPE AND ADMINISTRATION OF THE PLAN (Filed With SEC on July 25, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENT (Filed With SEC on July 25, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. STOCK OPTION GRANT NOTICE (2006 EQUITY INCENTIVE PLAN) (Filed With SEC on July 25, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. 2014 EQUITY INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on July 25, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. 2014 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK AWARD GRANT NOTICE (Filed With SEC on July 25, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. 2014 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE (Filed With SEC on July 25, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT AVALANCHE BIOTECHNOLOGIES, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on July 18, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (Filed With SEC on July 18, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. AMENDED AND RESTATED VOTING AGREEMENT (Filed With SEC on July 18, 2014)

INDEMNIFICATION AGREEMENT (Filed With SEC on July 18, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. CHANGE IN CONTROL BENEFIT PLAN (Filed With SEC on July 18, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. (a Delaware corporation) WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on June 30, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. WARRANT TO PURCHASE SERIES A PREFERRED STOCK (Filed With SEC on June 30, 2014)

EXCLUSIVE LICENSE BETWEEN AVALANCHEBIOTECHNOLOGIES, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR USE OF RECOMBINANTGENE DELIVERY VECTORS FOR TREATING OR PREVENTING... (Filed With SEC on June 30, 2014)

AMENDMENT # 1 TO: EXCLUSIVE LICENSE AGREEMENT FOR USE OF RECOMBINANTGENE DELIVERY VECTORS FOR TREATING OR PREVENTING DISEASES OF THE EYE UC Case No.: [***] (Filed With SEC on June 30, 2014)

RESEARCH COLLABORATION AND LICENSE AGREEMENT By and Between AVALANCHEBIOTECHNOLOGIES, INC. and REGENERON PHARMACEUTICALS, INC. Dated as of May 1, 2014 (Filed With SEC on June 30, 2014)

AVALANCHE BIOTECHNOLOGIES, INC. 2006 EQUITY INCENTIVE PLAN ADOPTED BY BOARD ON: DECEMBER 29, 2006 APPROVED BY STOCKHOLDERS: DECEMBER 29, 2006 TERMINATION DATE: DECEMBER 29, 2016 (Filed With SEC on June 30, 2014)

EXHIBIT A EMPLOYEE PROPRIETARY INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT EMPLOYEE CONFIDENTIAL INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT (Filed With SEC on June 30, 2014)

1035 OBrien Drive, Menlo Park, CA 9025 Tel ###-###-#### | Fax ###-###-#### (Filed With SEC on June 30, 2014)

665 Third Street, Suite 250, San Francisco, CA 94107 Tel ###-###-#### | Fax ###-###-#### (Filed With SEC on June 30, 2014)

EXHIBIT A EMPLOYEE PROPRIETARY INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT EMPLOYEE CONFIDENTIAL INFORMATION AND INVENTIONS ASSIGNMENT AGREEMENT (Filed With SEC on June 30, 2014)

LEASE AGREEMENT (NNN) Basic Lease Information (Filed With SEC on June 30, 2014)

Category

Industry

Companies

Contracts

Adverum Biotechnologies, Inc. Contracts & Agreements